Search Results 221-230 of 16993 for pharmacogenetics
Duvelisib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Chemotherapy drugs, such as CC-486, cyclophosphamide, ...
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
Caroline Grant, Ph.D. student at Mayo Clinic Graduate School of Biomedical Sciences, is researching Artificial Intelligence strategies to study disease and ...
She completed her residency training in child neurology and a fellowship in medical genetics at Mayo Clinic, Rochester, and is dual boarded in neurology and ...
Additionally, to perform RNA Sequencing and targeted metabolomics analysis to identify alterations in gene expression and metabolites associated with the NAD ...
Pharmacogenetic Testing in Children With Persistent Gastroesophageal Reflux Disease Rochester, MN. This study will use a 22 gene pharmacogenomics panel on 30 ...
The purpose of this study is to investigate the safety and tolerability of a single intravenous (IV) dose of SGT-501. Participation eligibility. Participant ...
About this study. The purpose of this investigation is to characterize the genetic and epigenetic characteristics of different musculoskeletal tissues, ...
Dr. Daniel Schaid's Statistical Genetics and Genetic Epidemiology Lab at Mayo Clinic develops and shares statistical methods and software about traits and ...
About this study. The purpose of this study is to establish the prevalence and severity of specific morbid indicators of disease severity such as specific ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.